GluA1 receptor and GluA1 knockout mice have been studied extensively in many aspects of neurological diseases and have been implicated in long-term potentiation, Alzheimer’s disease, schizophrenia, depression, sleep and wakefulness, epilepsy, and neuropathic pain26,31–36. This evidence concerns the gene GRIA1 and schizophrenia.